Prohibits pre-approval or precertification of prenatal ultrasound screenings covered under health benefits plans.
Impact
The bill is positioned to amend existing healthcare regulations affecting how ultrasound screenings are covered under health benefit plans. By eliminating the need for pre-approval, it aims to remove a bureaucratic hurdle that can lead to delays in receiving essential prenatal services. This change is anticipated to have a significant impact on expectant mothers, potentially improving maternal and fetal health outcomes by ensuring prompt access to these diagnostic procedures.
Summary
Bill S988 is designed to enhance access to prenatal ultrasound screenings by prohibiting health insurers, third-party administrators, and state health benefits programs from requiring pre-approval or precertification for these services. This initiative directly addresses concerns related to the accessibility of necessary prenatal care, ensuring that financial barriers do not delay or inhibit the timely provision of ultrasound screenings, which are critical for monitoring fetal health and development.
Contention
While the bill is generally aimed at promoting better health access, it may not be without criticism. Potential contention could arise around the implications for insurance providers and the financial liabilities they may face as a result of this change. Opponents may argue that removing the pre-approval requirement could lead to increased costs for insurers, which may in turn affect premium rates across health plans. Nevertheless, advocates of the bill assert that the benefits of improved access outweigh these concerns, emphasizing the importance of prenatal care in promoting healthier pregnancy outcomes.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Enacts the "health insurance preauthorization disclosure act"; requires health insurance companies to provide participating health care providers with a list of health care treatments and services that require preauthorization from the health insurance company.